URISPAS (flavoxate) Coupons, Discounts & Cost

URISPAS (flavoxate) Coupons, Discounts & Cost
Pharm.to ( visit store )
0 0
Comments Off
Want to say something? Add Comment 

Urispas (flavoxate) Coupons, Discounts & Cost

Urispas (flavoxate) is a drug with spasmolytic effect. One way to save money on the Urispas retail cost regardless of income and insurance status is to use Urispas coupons or discount cards from RXCoupons. Use this Flavoxate coupon at this online pharmacy and receive up to 75% off the sale price.

Urispas pharmacologic effect

Urispas (flavoxate) is a drug with spasmolytic effect. It acts mainly on the smooth muscles of the urinary tract. This drug is very popular and is often prescribed for inflammation of the urinary system and dysuria.

Flavoxate is an antispasmodic drug. It helps reduce smooth muscle tone (mainly the urinary tract). The drug eliminates spasms of smooth muscles of internal organs – gastrointestinal tract, biliary tract, urinary tract (bladder, urethra). It is effective in patients with cystitis, urethritis, prostatitis. The anti-inflammatory effect of flavoxate helps reduce the severity of the inflammatory process that occurs in the tissues of the urinary tract. Also, the drug removes pain in the urinary tract. In addition, flavoxate reduces pain and burning when urinating. The spasmolytic effect of the drug is achieved within 1 hour after administration.

Urispas indications: symptomatic treatment of dysuria, nocturia, cystitis, prostatitis, urethritis. Urispas may be used in combination treatment for prevention of recurrences of chronic infections of the urinary tract (especially cystitis). It is also used to prevent spasms associated with instrumental examination or bladder surgery.

Contraindications to the use of Urispas

The main contraindications include: hypersensitivity, obstructive diseases of the urinary tract, intestinal obstruction, gastrointestinal bleeding, achalasia, glaucoma, pregnancy, lactation, children under 12 years of age.

The drug is not recommended for patients with obstruction of the urinary tract. You should stop treatment with Urispas in case of intensive pain syndrome.

Side effects of Urispas

Adverse reactions associated with Urispas: dizziness, headache, drowsiness, nervousness, increased intraocular pressure, gastrointestinal discomfort, tachycardia, leukopenia, allergic reactions, nausea, vomiting, dry mouth, urticaria, hyperpyrexia.

CNS: dizziness, headache, drowsiness, nervousness, decreased visual acuity, increased intraocular pressure.

Flavoxate should be prescribed with caution to patients with glaucoma. Patients taking flavoxate should refrain from driving or doing any other things that require your attention (high risk of drowsiness or blurred vision).

Cardiovascular system: tachycardia.

Blood: leukopenia.

Digestive system: nausea, vomiting, dry mouth.

Other reactions: hives, dermatitis, hyperpyrexia.

Stop taking this drug in case of acute pain.

Urispas: dosing and administration

Adults and children over 12 years of age: 100-200 mg 3-4 times a day. The dose can be reduced when the symptoms of the disease become weaker or disappear.

The effectiveness of flavoxate in children younger than 12 years is not established. Therefore, children of this age should not use this drug.

Pregnant women and lactating mothers can take Urispas only if absolutely necessary.

Urispas: special instructions

No interactions with other drugs have been established. Nevertheless, do not take Urispas with immunosuppressive drugs.

There are no cases of overdose associated with Urispas therapy. Some individuals may experience minor gastrointestinal disorders (diarrhea, nausea, vomiting), skin reactions (itching, exanthema, erythema) and certain allergic reactions (small fever). There were cases of serious adverse events: edema of the oral cavity and peripheral edema. Treatment should be discontinued if you have more severe complications.

You should refrain from driving a car in case of drowsiness.

Urispas should only be used to treat life-threatening symptoms during pregnancy and lactation. This drug is not recommended for children under 12 years of age.

The duration of treatment is determined individually (patients should consult with their doctor).

Storage conditions: at room temperature, in the dark place.

Comments are closed.